C. Russell Trenary III

Insider Reports History

Entity
Individual
Location
1700 E St Andrew Place, Santa Ana, California
Signature
/s/ Lawrence Kenyon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by C. Russell Trenary III:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Outlook Therapeutics, Inc. CEO AND PRESIDENT, Director Stock Option (Right to Buy) 455K Mar 20, 2024 Direct

Insider Reports Filed by C. Russell Trenary III

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OTLK Outlook Therapeutics, Inc. Mar 20, 2024 1 $0 4 Mar 22, 2024 CEO AND PRESIDENT, Director
OTLK Outlook Therapeutics, Inc. Apr 17, 2023 1 $0 4 Apr 19, 2023 CEO and President, Director
OTLK Outlook Therapeutics, Inc. Jun 21, 2022 1 $21.1K 4 Jun 23, 2022 CEO and President, Director
OTLK Outlook Therapeutics, Inc. Mar 31, 2022 1 $0 4 Apr 4, 2022 CEO and President, Director
OTLK Outlook Therapeutics, Inc. Dec 6, 2021 1 $34.8K 4 Dec 6, 2021 CEO and President, Director
OTLK Outlook Therapeutics, Inc. Dec 2, 2021 1 $14K 4 Dec 2, 2021 CEO and President, Director
OTLK Outlook Therapeutics, Inc. Jul 6, 2021 1 $0 4 Jul 8, 2021 CEO and President, Director
OTLK Outlook Therapeutics, Inc. Jul 6, 2021 0 $0 3 Jul 8, 2021 CEO and President, Director